Clinical Scorecard: Investigating the Relationships Among Polysubstance Use, Social Determinants of Health, and Mental Health Symptoms in Individuals Living with HIV
At a Glance
Category
Detail
Condition
HIV infection with co-occurring substance use and mental health symptoms
Key Mechanisms
Polysubstance and single substance use correlate with increased social drivers of health (SDOH) risks and mental health symptom domains
Target Population
Persons with HIV (PWH) engaged in HIV care, including those with no, single, or polysubstance use
Care Setting
HIV clinical care settings, including infectious disease clinics
Key Highlights
Polysubstance use is strongly associated with increased risk in multiple SDOH domains such as transportation needs and food insecurity.
Substance using PWH have significantly higher odds of mental health symptoms including depression, mania, anxiety, and PTSD compared to non-substance using controls.
Substance use and mental health symptoms co-occur and exacerbate negative HIV-related health outcomes including medication adherence and viral suppression.
Guideline-Based Recommendations
Diagnosis
Assess substance use patterns (no use, single substance, polysubstance) via self-report and toxicology (urine and hair) in PWH.
Screen for social drivers of health risks including transportation needs and food insecurity.
Evaluate mental health symptom domains such as depression, mania, anxiety, and PTSD in PWH, especially those using substances.
Management
Integrate interventions targeting polysubstance use to address associated social and mental health risks.
Provide comprehensive care addressing both substance use and mental health symptoms to improve HIV outcomes.
Focus on modifiable social drivers of health to improve overall health-related outcomes in PWH.
Monitoring & Follow-up
Regularly monitor substance use patterns and mental health symptoms during HIV care visits.
Track changes in social drivers of health risk domains to identify emerging needs.
Assess HIV viral load and medication adherence in context of substance use and mental health status.
Risks
Polysubstance use increases risk for unmet social needs and mental health symptoms, which can worsen HIV treatment outcomes.
Co-occurring substance use and mental health issues are linked to higher rates of missed HIV care visits and lower viral suppression.
Patient & Prescribing Data
Persons with HIV using no substances, single substances, or multiple substances
Polysubstance use correlates with greater social and mental health risks, indicating need for tailored interventions beyond standard HIV treatment.
Clinical Best Practices
Incorporate routine screening for polysubstance use and associated social drivers of health in HIV clinical care.
Address mental health symptoms proactively in PWH with substance use to improve adherence and health outcomes.
Develop multidisciplinary approaches combining substance use treatment, mental health care, and social support services.
A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.
Longitudinal Swedish study finds physicians and nurses reporting problem drinking or illicit drug use had about twice the risk of rating their care as poor 1 year later
